Cargando…
Complications from Surgeries Related to Ovarian Cancer Screening
The aim of this study was to evaluate complications of surgical intervention for participants in the Kentucky Ovarian Cancer Screening Program and compare results to those of the Prostate, Lung, Colorectal and Ovarian Cancer Screening trial. A retrospective database review included 657 patients who...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5373025/ https://www.ncbi.nlm.nih.gov/pubmed/28282907 http://dx.doi.org/10.3390/diagnostics7010016 |
_version_ | 1782518740310556672 |
---|---|
author | Baldwin, Lauren A. Pavlik, Edward J. Ueland, Emma Brown, Hannah E. Ladd, Kelsey M. Huang, Bin DeSimone, Christopher P. van Nagell, John R. Ueland, Frederick R. Miller, Rachel W. |
author_facet | Baldwin, Lauren A. Pavlik, Edward J. Ueland, Emma Brown, Hannah E. Ladd, Kelsey M. Huang, Bin DeSimone, Christopher P. van Nagell, John R. Ueland, Frederick R. Miller, Rachel W. |
author_sort | Baldwin, Lauren A. |
collection | PubMed |
description | The aim of this study was to evaluate complications of surgical intervention for participants in the Kentucky Ovarian Cancer Screening Program and compare results to those of the Prostate, Lung, Colorectal and Ovarian Cancer Screening trial. A retrospective database review included 657 patients who underwent surgery for a positive screen in the Kentucky Ovarian Cancer Screening Program from 1988–2014. Data were abstracted from operative reports, discharge summaries, and office notes for 406 patients. Another 142 patients with incomplete records were interviewed by phone. Complete information was available for 548 patients. Complications were graded using the Clavien–Dindo (C–D) Classification of Surgical Complications and considered minor if assigned Grade I (any deviation from normal course, minor medications) or Grade II (other pharmacological treatment, blood transfusion). C–D Grade III complications (those requiring surgical, endoscopic, or radiologic intervention) and C–D Grade IV complications (those which are life threatening) were considered “major”. Statistical analysis was performed using SAS 9.4 software. Complications were documented in 54/548 (10%) subjects. For women with malignancy, 17/90 (19%) had complications compared to 37/458 (8%) with benign pathology (p < 0.003). For non-cancer surgery, obesity was associated with increased complications (p = 0.0028). Fifty patients had minor complications classified as C–D Grade II or less. Three of 4 patients with Grade IV complications had malignancy (p < 0.0004). In the Prostate, Lung, Colorectal and Ovarian Cancer Screening trial, 212 women had surgery for ovarian malignancy, and 95 had at least one complication (45%). Of the 1080 women with non-cancer surgery, 163 had at least one complication (15%). Compared to the Prostate, Lung, Colorectal and Ovarian Cancer Screening trial, the Kentucky Ovarian Cancer Screening Program had significantly fewer complications from both cancer and non-cancer surgery (p < 0.0001 and p = 0.002, respectively). Complications resulting from surgery performed as a result of the Kentucky Ovarian Cancer Screening Program were infrequent and significantly fewer than reported in the Prostate, Lung, Colorectal and Ovarian Cancer Screening trial. Complications were mostly minor (93%) and were more common in cancer versus non-cancer surgery. |
format | Online Article Text |
id | pubmed-5373025 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-53730252017-04-05 Complications from Surgeries Related to Ovarian Cancer Screening Baldwin, Lauren A. Pavlik, Edward J. Ueland, Emma Brown, Hannah E. Ladd, Kelsey M. Huang, Bin DeSimone, Christopher P. van Nagell, John R. Ueland, Frederick R. Miller, Rachel W. Diagnostics (Basel) Article The aim of this study was to evaluate complications of surgical intervention for participants in the Kentucky Ovarian Cancer Screening Program and compare results to those of the Prostate, Lung, Colorectal and Ovarian Cancer Screening trial. A retrospective database review included 657 patients who underwent surgery for a positive screen in the Kentucky Ovarian Cancer Screening Program from 1988–2014. Data were abstracted from operative reports, discharge summaries, and office notes for 406 patients. Another 142 patients with incomplete records were interviewed by phone. Complete information was available for 548 patients. Complications were graded using the Clavien–Dindo (C–D) Classification of Surgical Complications and considered minor if assigned Grade I (any deviation from normal course, minor medications) or Grade II (other pharmacological treatment, blood transfusion). C–D Grade III complications (those requiring surgical, endoscopic, or radiologic intervention) and C–D Grade IV complications (those which are life threatening) were considered “major”. Statistical analysis was performed using SAS 9.4 software. Complications were documented in 54/548 (10%) subjects. For women with malignancy, 17/90 (19%) had complications compared to 37/458 (8%) with benign pathology (p < 0.003). For non-cancer surgery, obesity was associated with increased complications (p = 0.0028). Fifty patients had minor complications classified as C–D Grade II or less. Three of 4 patients with Grade IV complications had malignancy (p < 0.0004). In the Prostate, Lung, Colorectal and Ovarian Cancer Screening trial, 212 women had surgery for ovarian malignancy, and 95 had at least one complication (45%). Of the 1080 women with non-cancer surgery, 163 had at least one complication (15%). Compared to the Prostate, Lung, Colorectal and Ovarian Cancer Screening trial, the Kentucky Ovarian Cancer Screening Program had significantly fewer complications from both cancer and non-cancer surgery (p < 0.0001 and p = 0.002, respectively). Complications resulting from surgery performed as a result of the Kentucky Ovarian Cancer Screening Program were infrequent and significantly fewer than reported in the Prostate, Lung, Colorectal and Ovarian Cancer Screening trial. Complications were mostly minor (93%) and were more common in cancer versus non-cancer surgery. MDPI 2017-03-08 /pmc/articles/PMC5373025/ /pubmed/28282907 http://dx.doi.org/10.3390/diagnostics7010016 Text en © 2017 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Baldwin, Lauren A. Pavlik, Edward J. Ueland, Emma Brown, Hannah E. Ladd, Kelsey M. Huang, Bin DeSimone, Christopher P. van Nagell, John R. Ueland, Frederick R. Miller, Rachel W. Complications from Surgeries Related to Ovarian Cancer Screening |
title | Complications from Surgeries Related to Ovarian Cancer Screening |
title_full | Complications from Surgeries Related to Ovarian Cancer Screening |
title_fullStr | Complications from Surgeries Related to Ovarian Cancer Screening |
title_full_unstemmed | Complications from Surgeries Related to Ovarian Cancer Screening |
title_short | Complications from Surgeries Related to Ovarian Cancer Screening |
title_sort | complications from surgeries related to ovarian cancer screening |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5373025/ https://www.ncbi.nlm.nih.gov/pubmed/28282907 http://dx.doi.org/10.3390/diagnostics7010016 |
work_keys_str_mv | AT baldwinlaurena complicationsfromsurgeriesrelatedtoovariancancerscreening AT pavlikedwardj complicationsfromsurgeriesrelatedtoovariancancerscreening AT uelandemma complicationsfromsurgeriesrelatedtoovariancancerscreening AT brownhannahe complicationsfromsurgeriesrelatedtoovariancancerscreening AT laddkelseym complicationsfromsurgeriesrelatedtoovariancancerscreening AT huangbin complicationsfromsurgeriesrelatedtoovariancancerscreening AT desimonechristopherp complicationsfromsurgeriesrelatedtoovariancancerscreening AT vannagelljohnr complicationsfromsurgeriesrelatedtoovariancancerscreening AT uelandfrederickr complicationsfromsurgeriesrelatedtoovariancancerscreening AT millerrachelw complicationsfromsurgeriesrelatedtoovariancancerscreening |